Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activation

Experimental and Molecular Medicine

Volumn 34, Issue 6, 2002, Pages 462-468

  Lee, Kye Young ^a   Park, Jae Seuk ^a   Jee, Young Koo ^a   Rosen, Glenn D ^b  

^a Dankook University College of Medicine   (South Korea)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antineoplastic agents; Apoptosis; Drug, Chinese herbal; Lung neoplasms; NF B; Tumor necrosis factor

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DITERPENE; HERBACEOUS AGENT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE RECEPTOR; SYNAPTOTAGMIN; TRIPTOLIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHINESE MEDICINE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LUNG CANCER; TRANSACTIVATION; TUMOR CELL DESTRUCTION;

TRIPTERYGIUM;

EID: 0037207259     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2002.64     Document Type: Article

References (35)

1. Aas T, Bborresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA, Lonning PA. Specific p53 mutations are associated with de novo resistance to doxorubicin in breastcancer patients. Na Med 1996;2:811-8
2. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8
3. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274:782-4
4. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L. Death receptor 5, a new mwmber of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-KB pathway. Immunity 1997;7:821-30
5. Fujiwara TE, Grimm A, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 1994;54:2287-91
6. Gazos Lopez U, Erhardt P, Yao R, Cooper GM. p53 dependent induction of apoptosis by proteosome inhibitors. J Biol Chem 1997;272:12893-6
7. Griffith TS, Lynch DH. TRAIL: a molecule with multiple receptors and control. Curr Opin Immunol 1998;10:559-63
8. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998;161:2833-40
9. Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM. Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells. Blood 1998;91:4624-31
10. Keane MM, Ettenberg SA, Nau MM, Russel EK, Lipkowitz S. Chemotherapy augments TRAIL-induced apoptosis in breast cancer cell lines. Cancer Res 1999;59:734-41
11. Kupchan SM, Court WA, Dailey RG, Jr, Gilmore CJ, Bryan RF. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc 1972; 94:7194-5
12. Lee KA, Binderreif A, Green MR. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal Tech 1988;5:2231
13. Lee KY, Chang WT, Qiu D, Kao PN, Rosen GD. PG490 (triptolide) cooperates with tumor necrosis factor-α to induce apoptosis in tumor cells. J Biol Chem 1999;274:13451-5.
14. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31
15. Lowe SW, Ruley HE, Jacks T, Houseman DE. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-68
16. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65
17. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa-B1 precursor protein and the activation of NFkappa-B. Cell 1994;78:773-85
18. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997;277:815-8
19. Pan G, Orourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM. The receptor for the cytotoxic ligand TRAIL. Science 1997;276:111-3
20. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996;271:12687-90
21. Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, Kao PN. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-κB transcriptional activation. J Biol Chem 1999;274:13443-50
22. Rosen GD, Barks JL, lademarco MF, Fisher RJ, Dean DC. An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. J Biol Chem 1994;269:15652-60
23. Shamon LA, et al. 1997. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett 112:113-7
24. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A. Control of TRAIL induced apoptosis by a family of signaling and decoy receptors. Science 1997;277:818-21
25. Shinohara K, Tomioka M, Nakano H, Tone S, Ito H, Kawashima S. Apoptosis induction resulting from protease inhibition. Biochem J 1996;317:385-8
26. Smith CA, Farrah T, Goodwin RG. The TNF-receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 1995;76:959-62
27. Tao X, Cai JJ, Lipsky PE. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F. J Pharmacol Exp Ther 1995;272:1305-12
28. Van Antwerp DJ, Martin SJ, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996;274:787-9
29. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH. Tumoricidal activity of tumor necrosis factor-related apoptosisinducing ligand in vivo. Nat Med 1999;5:157-63
30. Wang CY, Mayo MW, Jr. Baldwin AS. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996;274:784-7
31. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Jr. Baldwin AS. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-3
32. Wang D, Jr, Baldwin AS. Activation of nuclear factorkappaB-dependent transcription by tumor necrosis factoralpha is mediated through phosphorylation of ReIA/p65 on on serine 529. J Biol Chem 1998;273:29411-16
33. Wen LP, Fahrni JA, Troie S, Guan JL, Orth K, Rosen GD. Cleavage of focal adhesion kinase by caspase during apoptosis. J Biol Chem 1997;272:26056-61
34. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholi JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG. Identification and characterization of a new mwmber of the TNF family that induces apoptosis. Immunity 1995;3:673-82
35. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1998;1:661-71